The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
2012 · Proceedings of the National Academy of Sciences · 1,611 citations
https://doi.org/10.1073/pnas.1121623109
S
Stephen B. Willingham
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
69
Papers
9.4K
Citations
29
h-index
34
i10-index
Stephen B. Willingham is an academic researcher. The author has contributed to research in topics: Adenosine and Purinergic Signaling & Inflammasome and immune disorders & Phagocytosis and Immune Regulation. The author has an h-index of 29, co-authored 59 publications.
Papers by this author
worksCalreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47
2010 · Science Translational Medicine · 750 citations
https://doi.org/10.1126/scitranslmed.3001375
A CD47-associated super-enhancer links pro-inflammatory signalling to CD47 upregulation in breast cancer
2017 · Nature Communications · 222 citations
https://doi.org/10.1038/ncomms14802
Combining CD47 blockade with trastuzumab eliminates HER2-positive breast cancer cells and overcomes trastuzumab tolerance
2021 · Proceedings of the National Academy of Sciences · 119 citations
https://doi.org/10.1073/pnas.2026849118
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat